Angiodysplasia primary prevention

Angiodysplasia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Angiodysplasia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Angiodysplasia primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Angiodysplasia primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Angiodysplasia primary prevention
CDC on Angiodysplasia primary prevention
Angiodysplasia primary prevention in the news
Blogs on Angiodysplasia primary prevention
Directions to Hospitals Treating Angiodysplasia
Risk calculators and risk factors for Angiodysplasia primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nikita Singh, M.B.B.S.[2]

Primary Prevention

No method for primary prevention of angiodysplasia has been recognized till date. Long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) should be avoided due to its potentially damaging effects on both upper and lower GI.